35
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease

, , , , , , , , , , , , , & show all
Pages 1083-1087 | Published online: 08 Jul 2009

References

  • Sollid LM, Lundin KE. Coeliac disease. An inappropriate immune response. Lancet 2001;358 Suppl:S13.
  • Sollid LM. Molecular basis of celiac disease. AnnuRev Immunol 2000;18:53–81.
  • Greenberg DA, Lange KL. A maximum likelihood test of the two locus model for coeliac disease. Am J Med Genet 1982;12:75–82.
  • Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF, et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet 1996;14:329–33.
  • King AL, Fraser JS, Moodie SJ, Curtis D, Dearlove AM, Ellis HJ, et al. Coeliac disease: follow-up linkage study provides further support for existence of a susceptibility locus on chromosome 11p11. Ann Hum Genet 2001;65:377–86.
  • Karell K, Korponay-Szabo I, Szalai ZS, Holopainen P, Mustalahti K, Collin P, et al. Genetic dissection between coeliac disease and dermatitis herpetiformis in sib pairs. Ann Hum Genet 2002;66:387–92.
  • Collin P, Maki M, Keyrilainen O, Hallstrom O, Reunala T, Pasternack A. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992;27:367–71.
  • Mills FC, Harindranath N, Mitchell M, Max EE. Enhancer complexes located downstream of both human immunoglobulin C alpha genes. J Exp Med 1997;186:845–58.
  • Hu Y, Pan Q, Pardali E, Mills FC, Bernstein RM, Max EE, et al. Regulation of germline promoters by the two human Ig heavy chain 3′ alpha- enhancers. J Immunol 2000;164:6380–6.
  • Chen C, Birshtein BK. Virtually identical enhancers containing a segment of homology to murine 3′ IgH-E (HS 1,2) lie downstream of human Ig C alpha-1 and C alpha-2 genes. J Immunol 1997;159:1310–8.
  • Pinaud E, Aupetit C, Chauveau C, Cogne M. Identification of a homolog of the C alpha-3′/HS3 enhancer and of an allelic variant of the 3′IgH/HS1,2 enhancer downstream of the human immunoglobulin alpha-1 gene. Eur J Immunol 1997;27:2981–5.
  • Denizot Y, Pinaud E, Aupetit C, Le Morvan C, Magnoux E, Aldigier JC, et al. Polymorphism of the human alpha-1 immunoglobulin gene 3′ enhancer HS1,2 and its relation to gene expression. Immunol 2001;103: 35–40.
  • Aupetit C, Drouet M, Pinaud E, Denizot Y, Aldigier JC, Bridoux F, et al. Alleles of the alpha-1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Internat 2000;58:966–71.
  • Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346: 180–5.
  • Begovich AB, Moonsamy PV, Mack SJ, Barcellos LF, Steiner LL, Grams S, et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 2001;57:424–39.
  • Pinaud E, Khamlichi AA, Le Morvan C, Drouet M, Nalesso V, Le Bert M, et al. Localization of the 3′ IgH locus elements that effect long-distance regulation of class switch recombination. Immunity 2001;15: 187–99.
  • Stavnezer J. Molecular processes that regulate class switching. Curr Top Microbiol Immunol 2000;245:127–68.
  • Shanmugam A, Shi MJ, Yauch L, Stavnezer J, Kenter AL. Evidence for class-specific factors in immunoglobulin isotype switching. J Exp Med 2000;191:1365–80.
  • Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002;3:221–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.